Related Experiment Video

Updated: Sep 26, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Integrins and extracellular matrix: a novel mechanism of multidrug resistance

Tony Elliott1, Tariq Sethi

  • 1Centre for Inflammation Research, University of Edinburgh, Scotland, UK. Tony.Elliott@ed.ac.uk

Expert Review of Anticancer Therapy
|March 22, 2003
PubMed

Insights

Multidrug resistance in cancer is a major challenge. A newly identified mechanism, extracellular matrix-mediated resistance, involves cell adhesion and impacts anticancer drug effectiveness.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Multidrug resistance (MDR) significantly impedes effective cancer chemotherapy.
  • Established MDR mechanisms like drug efflux and enzymatic alterations have unclear clinical relevance.
  • Novel resistance pathways require investigation to improve treatment outcomes.

Purpose of the Study:

  • To investigate a novel mechanism of multidrug resistance mediated by the extracellular matrix.
  • To understand how cell adhesion to extracellular matrix proteins confers resistance to anticancer agents.
  • To identify potential new therapeutic targets for overcoming drug resistance in cancer.

Main Methods:

  • Investigated integrin-mediated cell adhesion to extracellular matrix proteins.
  • Assessed the impact of extracellular matrix adherence on cancer cell sensitivity to diverse anticancer drugs.
  • Analyzed the mechanisms underlying extracellular matrix-mediated multidrug resistance.

Main Results:

  • Identified extracellular matrix-mediated resistance as a significant factor in cancer drug resistance.
  • Demonstrated that integrin-mediated cell adhesion confers resistance to anticancer agents acting via various mechanisms.
  • Highlighted the potential clinical relevance of this novel resistance pathway.

Conclusions:

  • Extracellular matrix-mediated resistance presents a novel therapeutic challenge in oncology.
  • Targeting integrin-mediated adhesion may offer a strategy to overcome multidrug resistance.
  • Further research is needed to validate and exploit this mechanism for improved cancer therapy.

More Related Videos

2D and 3D Matrices to Study Linear Invadosome Formation and Activity12:25

2D and 3D Matrices to Study Linear Invadosome Formation and Activity

Published on: June 2, 2017

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...